KANUMA

Product NDC
25682-007
11-digit product format
256820007
Labeler code
25682
Product ID
25682-007_341de317-904b-4933-88da-b239c5989871
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Sebelipase alfa
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Labeler
Alexion Pharmaceuticals, Inc.
Application
BLA125561
Marketing category
BLA
Marketing start
2015-12-08
Substance
SEBELIPASE ALFA
Active strength
2 mg/mL
Pharmacologic classes
Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme [EPC], Hydrolytic Lysosomal Triacylglycerol-specific Enzyme [EPC], Sterol Esterase [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct25682-007IInactivated by FDA2026-08-07
excluded packagepackage25682-00725682-007-01IInactivated by FDA2026-08-07

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c32377c0-013b-4d9f-aa91-1267ea5fdb00Product name120160111

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
25682-007-01KANUMA10 mL in 1 VIAL, GLASSINJECTION, SOLUTION, CONCENTRATE1011
25682-007-01KANUMA1 in 1 CARTONINJECTION, SOLUTION, CONCENTRATE111

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
25682-007-01ML - Milliliter25682-007757985f0-c4d3-4be7-8357-855ff5bf44f612016-01-13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
25682-007KANUMA (SEBELIPASE ALFA) INJECTION, SOLUTION, CONCENTRATE [ALEXION PHARMACEUTICALS, INC.]10Current NDC, Legacy NDC, 2 package rows20240719_83a77b9d-42f0-4645-8420-786285da7326.zip

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125561Kanumasebelipase alfa351(a)Rx2026-06-01

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1726984Kanuma 20 MG in 10 ML InjectionPSN83a77b9d-42f0-4645-8420-786285da732611
1726979sebelipase alfa 20 MG in 10 ML InjectionPSN83a77b9d-42f0-4645-8420-786285da732611
172698410 ML sebelipase alfa 2 MG/ML Injection [Kanuma]SBD83a77b9d-42f0-4645-8420-786285da732611
172697910 ML sebelipase alfa 2 MG/ML InjectionSCD83a77b9d-42f0-4645-8420-786285da732611
172698410 ML Kanuma 2 MG/ML InjectionSY83a77b9d-42f0-4645-8420-786285da732611
1726984Kanuma 20 MG per 10 ML InjectionSY83a77b9d-42f0-4645-8420-786285da732611
1726979sebelipase alfa 20 MG per 10 ML InjectionSY83a77b9d-42f0-4645-8420-786285da732611

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
25682-007-01256820007011 VIAL, GLASS in 1 CARTON (25682-007-01) / 10 mL in 1 VIAL, GLASS2015-12-080000-00-00NoNoCurrent